dipyridamole has been researched along with Cardiovascular Diseases in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (38.46) | 18.7374 |
| 1990's | 6 (11.54) | 18.2507 |
| 2000's | 14 (26.92) | 29.6817 |
| 2010's | 10 (19.23) | 24.3611 |
| 2020's | 2 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y; Qiu, J; Xu, X; Yang, Y; Yue, H | 1 |
| Kuo, FC; Lee, MS; Liao, CY; Lu, YD; Tan, TL; Wu, CT | 1 |
| Chang, S; Chang, Y; Lu, S; Sun, Q; Zhang, Y | 1 |
| Babar, AK; Bui, L; DeGolovine, A; Gould, KL; Johnson, NP; Kitkungvan, D; Kumar, S; Madjid, M; Nacimbene, A; Patel, MB; Roby, AE; Vejpongsa, P | 1 |
| Bombardini, T; Ciampi, Q; Costantino, MF; Picano, E; Pratali, L; Sicari, R | 1 |
| Ciacciarelli, M; Iuliano, L; Violi, F; Zerbinati, C | 1 |
| Agostoni, P; Andreini, D; Aquaro, GD; Baggiano, A; Bartorelli, AL; Beltrama, V; Bertella, E; Conte, E; Giovannardi, M; Gripari, P; Guaricci, AI; Guglielmo, M; Loguercio, M; Masci, PG; Mushtaq, S; Pepi, M; Pontone, G; Rossi, C; Salerni, S; Segurini, C; Veglia, F | 1 |
| Rosenson, RS | 1 |
| Berger, JS; Hiatt, WR; Kittelson, JM; Krantz, MJ | 1 |
| Spinler, SA | 1 |
| Kössler, J; Steigerwald, U; Walter, U | 1 |
| Takagi, H; Umemoto, T | 1 |
| Capaldo, B; D'Errico, A; de Divitiis, O; Galderisi, M; Nosso, G; Riccardi, G; Sidiropulos, M; Turco, AA | 1 |
| Gebel, JM | 1 |
| Cid, E; Gould, KL; Johnson, NP; Kirkeeide, RL; Sdringola, S | 1 |
| Gewirtz, H | 1 |
| Valentine, N; Van de Laar, FA; van Driel, ML | 1 |
| Diener, HC | 1 |
| ROSINSKI, J | 1 |
| GONZALEZ MENENDEZ, E | 1 |
| ABERG, T; EKESTROEM, S | 1 |
| Behan, MW; Storey, RF | 1 |
| Belch, J; Betteridge, DJ; Brown, MM; Gent, M; Julian, D; Long, S; Morris, S; Pittard, J; Pye, M | 1 |
| Borges-Neto, S; Coleman, RE; Jain, D; Shaw, LK; Smith, WT; Tuttle, RH; Whellan, D | 1 |
| Moussouttas, M; Papamitsakis, N | 1 |
| Schuler, G | 1 |
| Bhatt, DL; Meadows, TA | 1 |
| Cella, G; Colby, SI; McCracken, L; Parisi, AF; Sasahara, AA; Taylor, AD | 1 |
| Giannini, SD; Guerra, JL; Merusse, JL; Sanchis, FS | 1 |
| Birgens, HS; Hansen, MS | 1 |
| Weiss, HJ | 1 |
| Moncada, S; Vane, JR | 1 |
| Turpie, AG | 1 |
| Boeynaems, JM | 1 |
| Butcher, RJ; Costello, JM; Menapace, FJ; Nassef, LA; Youkey, J | 1 |
| Alami, M; Aouad, A; Benjelloun, H; Benomar, M; Ghannam, R; Hajji, L; Ouraoui, T; Sadeli, S | 1 |
| Gibbs, CR; Lip, GY | 1 |
| Baker, RI; Hankey, GJ | 1 |
| Benhamou, PY; Cordonnier, D; Denis, B; Fagret, D; Halimi, S; Hammoud, T; Machecourt, J; Vanzetto, G | 1 |
| Accarino, M; Ambatiello, S; Buziashvili, Y; Del Rosso, GF; Di Giovanbattista, R; Djordjevic-Dikic, A; Lusa, AM; Matskeplishvili, S; Minardi, G; Pedrinelli, R; Picano, E; Pulignano, G; Ripoli, A; Sicari, R | 1 |
| Reverter, JC | 1 |
| Jobin, F | 1 |
| Bandinelli, C; Bellini, PG; De Mauro, G; Provvedi, D; Rubegni, M | 1 |
| Gantmacher, ML | 1 |
| Campbell, D; Hill, T; Kosinski, EJ; Lane, SE; Lewis, SM; Nesto, RW; Pippin, JJ | 1 |
| Borhani, NO | 1 |
| Gau, GT; Lavie, CJ; Squires, RW | 1 |
| Harker, LA | 1 |
| Grabner, H; Kohn, P; Vormittag, D; Vormittag, E; Zekert, F | 1 |
| Duchêne-Marullaz, P; Lavarenne, J | 1 |
| Matusczyk, H | 1 |
22 review(s) available for dipyridamole and Cardiovascular Diseases
| Article | Year |
|---|---|
Ginkgo leaf extract and dipyridamole injection for chronic cor pulmonale: a PRISMA-compliant meta-analysis of randomized controlled trials.
Topics: Cardiovascular Diseases; Chronic Disease; Dipyridamole; Drugs, Chinese Herbal; Ginkgo biloba; Humans; Hypertension, Pulmonary; Plant Extracts; Pulmonary Heart Disease; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
The Efficacy and Safety of 3 Types of Interventions for Stroke Prevention in Patients With Cardiovascular and Cerebrovascular Diseases: A Network Meta-analysis.
Topics: Anticoagulants; Aspirin; Bayes Theorem; Cardiovascular Diseases; Clopidogrel; Dabigatran; Dipyridamole; Hemorrhage; Humans; Odds Ratio; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Thiazoles; Ticlopidine; Treatment Outcome; Warfarin | 2017 |
Dipyridamole: a drug with unrecognized antioxidant activity.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Central Nervous System Diseases; Dipyridamole; Drug Discovery; Humans; Neoplasms; Oxidative Stress; Vasodilator Agents | 2015 |
Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.
Topics: Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic | 2009 |
Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.
Topics: Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Ticlopidine | 2009 |
[Anticoagulants of primary haemostasis].
Topics: Anticoagulants; Cardiovascular Diseases; Cerebrovascular Disorders; Dipyridamole; Hemostasis; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists | 2009 |
Heterogeneity of efficacy and safety of antiplatelet therapy in cardiovascular and cerebrovascular disease.
Topics: Acute Coronary Syndrome; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Ticlopidine | 2010 |
Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Diabetes Mellitus, Type 2; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Ticlopidine | 2012 |
Antiplatelet therapy in cardiovascular disease.
Topics: Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines | 2004 |
Combination antiplatelet agents in ischemic cerebrovascular disease.
Topics: Aspirin; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine | 2005 |
Clinical aspects of platelet inhibitors and thrombus formation.
Topics: Aspirin; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Cilostazol; Clopidogrel; Dipyridamole; Drug Resistance; Humans; Pentanoic Acids; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Pyridines; Receptor, PAR-1; Stents; Tetrazoles; Thrombosis; Thromboxanes; Ticlopidine | 2007 |
[Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Dextrans; Dipyridamole; Humans; Kidney Diseases; Sulfinpyrazone; Thrombosis | 1980 |
Platelet-active drugs in the secondary prevention of cardiovascular events: an overview.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Coronary Disease; Dipyridamole; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1980 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heart Diseases; Humans; Hydroxychloroquine; Neoplasms; Sulfinpyrazone; Thromboembolism; Thrombosis | 1982 |
Do we still need dipyridamole?
Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation Inhibitors | 1998 |
Antiplatelet drugs.
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Ticlopidine | 1999 |
[Platelet antiaggregants].
Topics: Aspirin; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Dipyridamole; Drug Utilization; Fibrinolytic Agents; Humans; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Risk Factors; Spain; Ticlopidine | 2000 |
[Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Analgesics; Anti-Inflammatory Agents; Arteriosclerosis; Aspirin; Blood Coagulation; Blood Platelets; Cardiovascular Diseases; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; In Vitro Techniques; Indomethacin; Oxyphenbutazone; Phenylbutazone; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Time Factors | 1976 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Female; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Male; Myocardial Infarction; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1979 |
Preventive cardiology: what is the value of antiplatelet agents and fish oils?
Topics: Aspirin; Cardiovascular Diseases; Coronary Thrombosis; Dipyridamole; Fish Oils; Humans; Platelet Aggregation Inhibitors; Thromboembolism | 1988 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Female; Glomerulonephritis; Graft Occlusion, Vascular; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thiophenes; Ticlopidine | 1986 |
[Recent data on coronary dilators].
Topics: Amino Alcohols; Aminophylline; Animals; Benzofurans; Cardiovascular Diseases; Cats; Coronary Disease; Dipyridamole; Dogs; Humans; Monoamine Oxidase Inhibitors; Nitrites; Papaverine; Prenylamine; Rabbits; Rats; Sympatholytics; Theophylline; Vasodilator Agents; Verapamil | 1968 |
4 trial(s) available for dipyridamole and Cardiovascular Diseases
| Article | Year |
|---|---|
Quantitative myocardial perfusion positron emission tomography and caffeine revisited with new insights on major adverse cardiovascular events and coronary flow capacity.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Aged; Caffeine; Cardiovascular Diseases; Coronary Circulation; Dipyridamole; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles | 2019 |
Treatment with aspirin and dipyridamole is more effective than aspirin in reducing low shear blood viscosity.
Topics: Adult; Aged; Aspirin; Blood Viscosity; Cardiovascular Diseases; Dipyridamole; Female; Hematocrit; Humans; Hyperhomocysteinemia; Male; Middle Aged; Platelet Aggregation Inhibitors | 2008 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heart Diseases; Humans; Hydroxychloroquine; Neoplasms; Sulfinpyrazone; Thromboembolism; Thrombosis | 1982 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Female; Glomerulonephritis; Graft Occlusion, Vascular; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thiophenes; Ticlopidine | 1986 |
28 other study(ies) available for dipyridamole and Cardiovascular Diseases
| Article | Year |
|---|---|
Does preoperative dipyridamole-thallium scanning reduce 90-day cardiac complications and 1-year mortality in patients with femoral neck fractures undergoing hemiarthroplasty?
Topics: Age Factors; Aged; Aged, 80 and over; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Comorbidity; Dipyridamole; Female; Femoral Neck Fractures; Hemiarthroplasty; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Operative Time; Propensity Score; Risk Factors; Thallium; Time Factors; Unnecessary Procedures | 2020 |
End-systolic elastance and ventricular-arterial coupling reserve predict cardiac events in patients with negative stress echocardiography.
Topics: Aged; Blood Pressure; Cardiovascular Diseases; Dipyridamole; Dobutamine; Echocardiography; Exercise; Female; Humans; Male; Middle Aged; Prognosis; Stress, Psychological | 2013 |
Prognostic value of dipyridamole stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a mid-term follow-up study.
Topics: Aged; Cardiovascular Diseases; Chest Pain; Contrast Media; Coronary Artery Disease; Dipyridamole; Exercise Test; Female; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Perfusion Imaging; Myocardial Revascularization; Prognosis; Vasodilator Agents | 2016 |
Aspirin for prevention of stroke and cardiovascular events among patients with peripheral artery disease.
Topics: Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Publication Bias | 2009 |
Coronary vasoreactivity is not altered in young people with type 1 diabetes.
Topics: Adult; Analysis of Variance; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Coronary Circulation; Coronary Vessels; Diabetes Mellitus, Type 1; Dipyridamole; Female; Humans; Linear Models; Male; Microcirculation; Risk Factors; Young Adult | 2010 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronary Circulation; Dipyridamole; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Myocardial Perfusion Imaging; Positron-Emission Tomography; Predictive Value of Tests; Reference Values; Reproducibility of Results; Risk Assessment; Risk Factors; Rubidium Radioisotopes; Vasodilator Agents; Young Adult | 2011 |
Quantitative PET measurements of myocardial blood flow in young, healthy volunteers what should we expect?
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Coronary Circulation; Dipyridamole; Fractional Flow Reserve, Myocardial; Humans; Myocardial Perfusion Imaging; Positron-Emission Tomography; Predictive Value of Tests; Reference Values; Reproducibility of Results; Risk Assessment; Risk Factors; Rubidium Radioisotopes; Vasodilator Agents; Young Adult | 2011 |
Aspirin therapy should be first-line treatment in secondary prevention of stroke--against.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk; Stroke; Ticlopidine; Treatment Outcome | 2002 |
[Therapeutic experiences with persantin (possibilities of evaluation of the results of therapy)].
Topics: Cardiovascular Diseases; Dipyridamole; Vasodilator Agents | 1960 |
[Incomplete AV block. Further aspects of its therapy].
Topics: Adrenal Cortex Hormones; Atrioventricular Block; Cardiovascular Diseases; Dipyridamole; Heart Block; Heparinoids; Humans; Hyaluronoglucosaminidase; Sympathomimetics | 1963 |
EFFECT OF PERSANTIN ON SPONTANEOUS VENTRICULAR FIBRILLATION IN DOGS IN DEEP HYPOTHERMIA. AN EXPERIMENTAL STUDY.
Topics: Animals; Bradycardia; Cardiovascular Diseases; Dipyridamole; Dogs; Electrocardiography; Heart; Heart, Artificial; Hypothermia; Hypothermia, Induced; Pharmacology; Research; Ventricular Fibrillation | 1963 |
Guidelines on the management of secondary prophylaxis of vascular events in stable patients in primary care.
Topics: Acute Disease; Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Artery Bypass; Dipyridamole; Endarterectomy, Carotid; Humans; Life Style; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Secondary Prevention; Stents; Ticlopidine; Treatment Outcome | 2004 |
Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi.
Topics: Adenosine; Aged; Cardiovascular Diseases; Coronary Circulation; Coronary Disease; Dipyridamole; Dobutamine; Exercise Test; Female; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Proportional Hazards Models; Risk Assessment; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2004 |
[Germany's girths in an international comparison].
Topics: Abdominal Fat; Adult; Anthropometry; Aspirin; Aspirin, Dipyridamole Drug Combination; Body Mass Index; Cardiovascular Diseases; Cerebral Infarction; Combined Modality Therapy; Cross-Cultural Comparison; Dipyridamole; Drug Combinations; Female; Germany; Humans; Male; Practice Guidelines as Topic; Secondary Prevention; United Kingdom | 2005 |
Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders.
Topics: Adult; Aged; Aspirin; beta-Thromboglobulin; Blood Coagulation Factors; Cardiovascular Diseases; Dipyridamole; Female; Heparin; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Count; Platelet Factor 4 | 1983 |
[Cardiovascular lesions induced in rats by vitamin D. Possible protective effect of sulfinpyrazone].
Topics: Animals; Arteries; Cardiovascular Diseases; Dipyridamole; Male; Myocardium; Necrosis; Oxyphenbutazone; Rats; Rats, Inbred Strains; Sulfinpyrazone; Vitamin D | 1983 |
The anti-thrombotic effects of prostacyclin.
Topics: Animals; Arteries; Aspirin; Cardiovascular Diseases; Dipyridamole; Epoprostenol; Fatty Acids; Hemostasis; Homeostasis; Humans; Lipid Peroxides; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxane A2 | 1980 |
[Prevention of cardiovascular diseases by inhibitors of platelet aggregation (author's transl)].
Topics: Anti-Inflammatory Agents; Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1982 |
Dipyridamole thallium imaging: use in preoperative cardiac risk assessment in vascular surgical patients.
Topics: Aged; Cardiovascular Diseases; Cohort Studies; Dipyridamole; Heart; Humans; Postoperative Complications; Predictive Value of Tests; Preoperative Care; Radionuclide Imaging; Retrospective Studies; Risk Factors; Thallium Radioisotopes; Vascular Surgical Procedures | 1993 |
[Dipyridamole stress myocardial scintigraphy].
Topics: Adult; Aged; Cardiovascular Diseases; Coronary Angiography; Dipyridamole; Exercise Test; Female; Humans; Male; Middle Aged; Radionuclide Imaging; Thallium Radioisotopes; Vasodilator Agents | 1997 |
Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.
Topics: Activities of Daily Living; Aged; Analysis of Variance; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipyridamole; Exercise; Exercise Test; Female; Heart; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Risk Factors; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 1999 |
Perioperative prognostic value of dipyridamole echocardiography in vascular surgery: A large-scale multicenter study in 509 patients. EPIC (Echo Persantine International Cooperative) Study Group.
Topics: Aged; Cardiovascular Diseases; Dipyridamole; Echocardiography; Humans; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Vascular Surgical Procedures | 1999 |
Antiplatelet drugs in cardiovascular prevention: take adverse effects and costs into account.
Topics: Aspirin; Cardiovascular Diseases; Cost-Benefit Analysis; Dipyridamole; Drug Costs; Flurbiprofen; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2000 |
[Anti-platelet aggregating drugs in the prevention of thromboembolic diseases].
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Cardiovascular Diseases; Cerebrovascular Disorders; Chromonar; Dextrans; Dipyridamole; Histamine H1 Antagonists; Humans; Kidney Diseases; Platelet Adhesiveness; Platelet Aggregation; Pyrimidines; Sulfinpyrazone; Thromboembolism; Thrombosis; Tranquilizing Agents | 1975 |
Predictive value of quantitative dipyridamole-thallium scintigraphy in assessing cardiovascular risk after vascular surgery in diabetes mellitus.
Topics: Angina Pectoris; Cardiovascular Diseases; Diabetic Angiopathies; Dipyridamole; Electrocardiography; Humans; Postoperative Complications; Predictive Value of Tests; Thallium Radioisotopes; Vascular Surgical Procedures | 1989 |
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; Coronary Disease; Dextrothyroxine; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Estrogens; Humans; Hypertension; Myocardial Infarction; Niacin; Sulfinpyrazone | 1985 |
[Medicamentous prophylaxis of postoperative cardiovascular complications (author's transl)].
Topics: Aged; Cardiovascular Diseases; Digitalis Glycosides; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Postoperative Care; Postoperative Complications; Preoperative Care; Thromboembolism | 1974 |
[A new combination--Persumbran--in balneological practice].
Topics: Adult; Aged; Balneology; Cardiovascular Diseases; Dipyridamole; Female; Humans; Male; Middle Aged; Oxazepam | 1967 |